New classes of drugs are being introduced that act only on the eye’s drainage canal. It is known as trabecular meshwork. It is a main outflow and blockade side of glaucoma. Rho kinase inhibitors target cells in the trabecular meshwork to enhance aqueous humor outflow. It is a clear fluid that maintains the intraocular pressure. In the research works it has shown that it reduces cellular stiffness. ROCK inhibition has the ability to offer neuroprotective and anti-inflammatory effects and also has the ability to enhance blood flow to the optic nerve.
Related Journals of Glaucoma Drugs Research
Optometry: Open Access, International Journal of Ophthalmic Pathology, Journal of Clinical & Experimental Ophthalmology, Journal of Current Glaucoma Practice, Journal of Glaucoma, Current Eye Research, Current Opinion in ophthalmology, International Ophthalmology, Japanese Journal of Clinical Ophthalmology, Japanese Journal of Ophthalmology, Journal Francais d'Ophtalmologie.